Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

iNKT cells can help prevent and treat alopecia areata by promoting hair regrowth.

Most skin changes during pregnancy are harmless and temporary, but some can risk the fetus and need careful treatment.

The study found a specific pattern of uneven melanin distribution on balding scalps that could help understand skin diseases caused by light exposure.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

Nearly half of the French individuals surveyed reported having a sensitive scalp, more common in women, often linked to hair loss and symptoms like itching, and triggered by factors including shampoos and pollution.

Neuropeptides affect skin inflammation, repair, and hair growth, with potential for therapy.

Alopecia Areata is an autoimmune disease causing hair loss in patches, often starting before age 20, and while some cases recover on their own, treatments include topical corticosteroids, minoxidil, and promising new methods like IL-31 antibodies and 308-nm Excimer laser therapy.

Polycystic Ovary Syndrome (PCOS) is a complex disorder with both immediate and long-term health effects, including menstrual issues, infertility, and increased risk of diabetes and heart disease.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

Vitamin D affects many body functions and its interaction with microRNAs could help treat related diseases.

COVID-19 may cause hair loss conditions like alopecia areata and telogen effluvium.

The study concluded that severity of Frontal fibrosing alopecia is not linked to how long someone has it, can start before menopause, and eyebrow loss may be an early sign.

Both genetic and lifestyle factors significantly affect female hair loss.

Alopecia areata causes hair loss and life quality issues; current treatments are often unsatisfactory, but new drugs like JAK inhibitors show promise.

A 45-year-old woman with autoimmune diseases experienced patchy hair loss due to alopecia areata, which has no cure but can be treated, with varying success.

New treatments for alopecia areata, like JAK inhibitors and immunomodulators, are promising.

Traction alopecia is more common in African women than girls, especially when traction is applied to chemically relaxed hair; avoiding such hairstyles may reduce the risk.

Hair can be used to measure cancer-related chemicals noninvasively.

Hair length and thickness are related, with thickness peaking at about a quarter of the hair's maximum length.

A hormone affects hair growth, certain molecules may prevent skin damage, a skin disease is linked to immune cells, glycerol helps skin hydration, and psoriasis treatment trials need improvement.

Environmental factors can trigger alopecia areata in identical twins.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Measuring cortisol in hair helps understand stress and manage related health issues.

Most patients with autoimmune blistering diseases experienced some hair loss, which may be underreported and linked to disease severity.

Early exposure to germs may protect against autoimmune diseases, lack of sex increases alcohol preference in fruit flies, a potential baldness treatment could involve blocking a specific receptor, skin memory cells help prevent re-infection, high-fat diets can affect brain cells related to weight, and the link between social status, stress, and heart disease in primates is unclear.

COVID-19 can increase the risk of hair loss, especially in people over 40.

Understanding skin's structure and function is crucial for grasping skin health and diseases.

Genes affect cytokine production, which can influence chronic diseases, and certain interventions may help prevent related molecular damage.

Hair shedding after COVID-19 is more linked to the disease's severity and inflammation rather than hormones, with women at higher risk.